Table 1.
Antibacterial peptides derived from LfcinB in this study.
| Peptide | Sequence |
m/z [M+H]+ |
Net chargea | GRAVYa | pIb | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motif | 20 R | R | W | Q | W | R 25 | 986.7 | +3 | −3.133 | 12.30 | |||||||||
| Palindromic | R | W | Q | W | R | W | Q | W | R | 1488.6 | +3 | −2.678 | 12.30 | ||||||
| LfcinB reference | 17F | K | C | R | R | W | Q | W | R | M | K | K | L | G | A31 | 1994.7 | +6 | −1.207 | 11.74 |
| Dimeric | (R | R | W | Q | W | R) 2 | K | Ahx | 2198.5 | +6 | - - | - - | |||||||
| Tetrameric | (R | R | W | Q | W | R) 4 | K2 | Ahx2 | C2 | 4594.6 | +12 | - - | - - | ||||||
aNet charge and grand average of hydropathy (GRAVY) were calculated using the Antimicrobial Peptide Calculator and Predictor (http://aps.unmc.edu/AP/prediction/prediction_main.php). bTheoretical pI values were calculated using the Compute pI/Mw Tool (https://web.expasy.org/compute_pi/).